The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - November 8, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Two decades with omalizumab: what we still have to learn
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - October 25, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Analysis of real-world treatment patterns in a matched rheumatology population that continued innovator infliximab therapy or switched to biosimilar infliximab
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - October 24, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Designing of CD8+ and CD8+-overlapped CD4+ epitope vaccine by targeting late and early proteins of human papillomavirus
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - October 1, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
A descriptive analysis of real-world treatment patterns of innovator (Remicade & reg;) and biosimilar infliximab in an infliximab-na & iuml;ve Turkish population
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - October 1, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Focus on biosimilar etanercept & ndash; bioequivalence and interchangeability
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - August 29, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - August 20, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn & rsquo;s disease
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - July 19, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
The conundrum of indeterminate QuantiFERON-TB Gold results before anti-tumor necrosis factor initiation
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - February 27, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - February 9, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - January 30, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Analytical characterization of recombinant hCG and comparative studies with reference product
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - January 30, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - January 17, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor- & alpha; inhibitors in clinical practice
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - January 12, 2018 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
(Source: Biologics: Targets and Therapy)
Source: Biologics: Targets and Therapy - December 14, 2017 Category: Biochemistry Tags: Biologics: Targets and Therapy Source Type: research
